The 12th International Conference on HIV Persistence & Eradication and Respi-DART 2026


KEY ABSTRACT DEADLINES

Abstract submissions are open for both conferences — please help us spread the word before these dates:


A MUTUAL PARTNERSHIP

In gratitude for your endorsement, we are delighted to promote your organization to the combined community of HIV Persistence and Respi-DART attendees, exhibitors, and mailing list subscribers — HIV researchers, respiratory virologists, clinicians, and public health professionals worldwide.

Please let us know if your organization has specific format preferences for posting or sharing information — we are happy to adapt materials as needed.


WHAT’S INSIDE THIS KIT

  • Key abstract deadlines for both conferences, highlighted up front
  • Conference highlights for both HIV Persistence 2026 and Respi-DART 2026
  • A combined email newsletter template promoting both conferences and both abstract deadlines, with clickable links
  • Social media templates for X (Twitter), LinkedIn, Facebook, and Instagram — per-conference sets, plus combined posts promoting both meetings together
  • Call-for-abstracts templates with each conference’s submission deadline
  • Tips for sharing, tagging, and pasting cleanly

HIV Persistence 2026

December 6–9, 2026  •  Hacienda del Mar Resort, Los Cabos, Mexico  •  www.hivpersistence.com

Abstract deadline: August 21, 2026 — oral and poster submissions at www.hivpersistence.com/abstracts

  • Focus on cutting-edge HIV reservoir biology, virology, and immunology
  • Sessions on novel therapeutics: latency reversal, block-and-lock, bNAbs, gene/CAR-T, lenacapavir-class agents
  • Clinical studies on ATIs, biomarkers, post-treatment control, and pediatric cure research
  • Abstract-driven program with priority given to young and early-career investigators; scholarships available
  • New this year: first-of-its-kind partnership with HIV-DART

Respi-DART 2026

December 9–11, 2026  •  Hacienda del Mar Resort, Los Cabos, Mexico  •  registration and abstracts via respidart.com

Late-breaking abstract deadline: September 17, 2026 — submit at respidart.com/abstracts

  • Focus on drug discovery and antiviral development for respiratory and re-emerging viruses
  • Sessions on RSV, influenza, long COVID, and pandemic preparedness
  • Coverage of emerging and re-emerging threats: dengue, chikungunya, yellow fever, Nipah, norovirus
  • Gertrude Elion DART Achievement Award session honoring leaders in antiviral science
  • Dedicated Industry Session and abstract slots reserved for early-career investigators